The impact of pancreatic enzyme supplementation on postprandial responses of glucagon-like Peptide-2 in patients with chronic pancreatitis and pancreatic exocrine insufficiency

JOP. 2010 Sep 6;11(5):489-91.
No abstract available

Publication types

  • Controlled Clinical Trial
  • Letter

MeSH terms

  • Enzyme Replacement Therapy* / methods
  • Exocrine Pancreatic Insufficiency / blood
  • Exocrine Pancreatic Insufficiency / complications
  • Exocrine Pancreatic Insufficiency / drug therapy*
  • Exocrine Pancreatic Insufficiency / metabolism
  • Female
  • Gastrointestinal Agents / therapeutic use
  • Glucagon-Like Peptide 1 / blood
  • Glucagon-Like Peptide 1 / metabolism
  • Glucagon-Like Peptide 2 / blood
  • Glucagon-Like Peptide 2 / metabolism*
  • Humans
  • Male
  • Pancreas / enzymology
  • Pancreatitis, Chronic / blood
  • Pancreatitis, Chronic / complications
  • Pancreatitis, Chronic / drug therapy*
  • Pancreatitis, Chronic / metabolism
  • Pancrelipase / therapeutic use*
  • Postprandial Period* / drug effects

Substances

  • Gastrointestinal Agents
  • Glucagon-Like Peptide 2
  • Pancrelipase
  • Glucagon-Like Peptide 1